Follow the Uni-Bio Science Group Ltd. stock price and the full insider trade history of the company, a publicly traded company based in Hong Kong. Shares are listed on HK HK, under the authority of HKEX. Operating in the Health Care sector, Uni-Bio Science Group Ltd. has published 5 public disclosures. Market capitalisation: €507.6m. The latest transaction was filed on 29 June 2026 (Purchase). Among the most active insiders: LEUNG KINGSLEY. The full history is accessible without an account.
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
5 of 5 declarations
Uni-Bio Science Group Ltd. is a company focused on the healthcare and pharmaceutical sector, specializing in the development of biopharmaceutical products. It is listed on the Hong Kong Stock Exchange (XHKG).